Kate Garrett

Kate is a Managing Partner at Sonder Capital and Assistant Director of the Stanford Biodesign Innovation Fellowship. Prior to Sonder Capital she was CEO of Ciel Medical, which she co-founded out of the Biodesign Innovation Fellowship. Ciel was acquired by Vyaire Medical in 2017, and Kate transitioned to Vice President of Airway Technologies at Vyaire. Previously, she was a strategic marketing consultant at Acclarent and an R&D engineer at Pathway Medical. Kate has co-authored over a dozen patents and has received multiple honorary fellowships including being one of the first recipients of the Ferolyn Fellowship. She is board director at BRIUS Technologies, Spirair, Ziteo Medical and ClearClub and a member of the Caltech Seed Fund Investment Advisory Committee. She holds a bachelor’s degree in mechanical engineering from Olin College of Engineering.